Accredited official statistics

Gram-negative, MRSA, MSSA bacteraemia and C. difficile infections, from August 2025 to August 2026: monthly data trends

Updated 7 October 2026

This bulletin provides a brief overview of all cases reported through the national mandatory surveillance of bacteraemia and C. difficile infections (CDI) for the latest month.

The UK Health Security Agency (UKHSA) data dashboard presents supplementary monthly data visualisations of trends covering the latest 13-month period, with options to filter data by location. For longer term trends, detailed epidemiological commentaries covering the period from the beginning of surveillance onward are presented within the quarterly and annual reports, within this statistical series.

Help us improve this resource

We would like feedback on our proposal to stop publishing the commentary that accompanies the monthly tables. The tables would be unchanged. Please use the feedback button to give feedback on this proposal and to share your thoughts on MRSA, MSSA and Gram-negative bacteraemia and CDI (HCAI) monthly official statistics published by UKHSA.

The survey will take 5 to 10 minutes to complete and it is anonymous.

Main points

Escherichia coli (E. coli) bacteraemia

In August 2026:

• overall, 4,144 E. coli bacteraemia cases were reported, a decrease of 1.4% when compared with the same month of the previous year (n=4,204)

• hospital-onset, healthcare-associated (HOHA) E. coli bacteraemia cases decreased by 6.6% (n=695) when compared with the same month of the previous year (n=744)

• community-onset, healthcare-associated (COHA) E. coli bacteraemia cases decreased by 2.2% (n=590) when compared with the same month of the previous year (n=603)

• community-onset, community-associated (COCA) E. coli bacteraemia cases did not change substantially (n=2,857) when compared with the same month of the previous year (n=2,856)

Klebsiella species (spp.) bacteraemia

In August 2026:

• overall, 1,315 Klebsiella spp. bacteraemia cases were reported, an increase of 2.6% when compared with the same month of the previous year (n=1,282)

• HOHA Klebsiella spp. bacteraemia cases increased by 7.3% (n=395) when compared with the same month of the previous year (n=368)

• COHA Klebsiella spp. bacteraemia cases increased by 8.1% (n=200) when compared with the same month of the previous year (n=185)

• COCA Klebsiella spp. bacteraemia cases decreased by 1.0% (n=719) when compared with the same month of the previous year (n=726)

Pseudomonas aeruginosa (P. aeruginosa) bacteraemia

In August 2026:

• overall, 453 P. aeruginosa bacteraemia cases were reported, an increase of 3.4% when compared with the same month of the previous year (n=438)

• HOHA P. aeruginosa bacteraemia cases increased by 1.9% (n=163) when compared with the same month of the previous year (n=160)

• COHA P. aeruginosa bacteraemia cases increased by 8.2% (n=92) when compared with the same month of the previous year (n=85)

• COCA P. aeruginosa bacteraemia cases increased by 2.6% (n=198) when compared with the same month of the previous year (n=193)

Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia

In August 2026:

• overall, 112 MRSA bacteraemia cases were reported, an increase of 34.9% when compared with the same month of the previous year (n=83)

• HOHA MRSA bacteraemia cases increased by 14.3% (n=32) when compared with the same month of the previous year (n=28)

• COHA MRSA bacteraemia cases increased by 50.0% (n=15) when compared with the same month of the previous year (n=10)

• COCA MRSA bacteraemia cases increased by 44.4% (n=65) when compared with the same month of the previous year (n=45)

Meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia

In August 2026:

• overall, 1,218 MSSA bacteraemia cases were reported, an increase of 4.9% when compared with the same month of the previous year (n=1,161)

• HOHA MSSA bacteraemia cases increased by 12.0% (n=345) when compared with the same month of the previous year (n=308)

• COHA MSSA bacteraemia cases increased by 4.3% (n=171) when compared with the same month of the previous year (n=164)

• COCA MSSA bacteraemia cases increased by 2.0% (n=702) when compared with the same month of the previous year (n=688)

C. difficile infections (CDI)

In August 2026:

• overall, 1,579 CDI cases were reported, a decrease of 2.8% when compared with the same month of the previous year (n=1,624)

• HOHA CDI cases increased by 0.1% (n=678) when compared with the same month of the previous year (n=677)

• COHA CDI cases decreased by 2.3% (n=292) when compared with the same month of the previous year (n=299)

• community-onset, indeterminate-association (COIA) CDI cases decreased by 5.8% (n=161) when compared with the same month of the previous year (n=171)

• COCA CDI cases decreased by 6.1% (n=448) when compared with the same month of the previous year (n=477)

Data sources and methodology

For further information on our data sources and methodology used to analyse data in this report, please refer to our quality and methodology information (QMI) report. Due to month-to-month fluctuations and potential shifts in seasonal patterns across the year, comparisons between individual months to the corresponding month in the previous year should be interpreted with caution.

Background information

This publication forms part of the range of accredited official statistics outputs routinely published by UKHSA which include monthly and annual reports on the mandatory surveillance of E. coli, Klebsiella spp., P. aeruginosa, MRSA and MSSA bacteraemia and CDI.

Data for this report was extracted from UKHSA’s healthcare-associated infections (HCAI) data capture system (DCS) on 16 September 2026.

Further information and contact details

Feedback and contact information

For any enquiries or feedback on this report, or to request copies of this report in PDF format, please contact mandatory.surveillance@ukhsa.gov.uk

Accredited official statistics

Our statistical practice is regulated by the Office for Statistics Regulation (OSR). OSR sets the standards of trustworthiness, quality and value in the Code of Practice for Statistics that all producers of Official Statistics should adhere to. You are welcome to contact us directly at mandatory.surveillance@ukhsa.gov.uk with any comments about how we meet these standards. Alternatively, you can contact OSR by emailing regulation@statistics.gov.uk or via the OSR website.

These official statistics were independently reviewed by the OSR in May 2022. They comply with the standards of trustworthiness, quality and value in the Code of Practice for Statistics and should be labelled ‘accredited official statistics’. Accredited official statistics are called National Statistics in the Statistics and Registration Service Act 2007. Further explanation of accredited official statistics can be found on the Office for Statistics Regulation website.